SCHEDULE: Armistice Capital Reports 4.99% Stake in Creative Medical
Beneficial Ownership Report
Armistice Capital, LLC and Steven Boyd have reported a 4.99% beneficial ownership stake in Creative Medical Technology Holdings, Inc. through a Schedule 13G filing.
Summary
- Armistice Capital, LLC and Steven Boyd are the reporting persons for this beneficial ownership statement.
- They collectively beneficially own 135,531 shares of Creative Medical Technology Holdings, Inc. Common Stock.
- This ownership represents 4.99% of the total class of securities.
- Armistice Capital, LLC, as the investment manager, and Steven Boyd, as its managing member, exercise shared voting and dispositive power over these shares.
- The shares are directly held by Armistice Capital Master Fund Ltd., an investment advisory client of Armistice Capital, LLC.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership, indicating a passive investment. It contains no positive or negative operational or financial news about the issuer, resulting in a neutral sentiment.
Positives
- The disclosure of a significant, albeit passive, stake by an institutional investor like Armistice Capital may signal a degree of confidence in the company's long-term prospects.
Future Outlook
This filing is a beneficial ownership report and does not contain forward-looking statements or guidance from the issuer.
Management Comments
- Steven Boyd, as Managing Member of Armistice Capital, LLC, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose or with the effect of changing or influencing the control of the issuer.
Industry Context
This filing is a standard disclosure of institutional ownership and does not provide specific insights into broader industry trends or competitive positioning for Creative Medical Technology Holdings, Inc.
Stakeholder Impact
- Shareholders are informed of a significant institutional investor's passive stake in the company.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of the event which required the filing of this statement. |
| 08/14/2025 | Date the Schedule 13G statement was signed by the reporting persons. |
Keywords
Creative Medical Technology Holdings, Armistice Capital, Steven Boyd, Beneficial Ownership, Schedule 13G, Common Stock, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.